Logo image of DEX.DE

DELTICOM AG (DEX.DE) Stock Fundamental Analysis

FRA:DEX - Deutsche Boerse Ag - DE0005146807 - Common Stock - Currency: EUR

2.25  -0.01 (-0.44%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to DEX. DEX was compared to 50 industry peers in the Specialty Retail industry. DEX has a medium profitability rating, but doesn't score so well on its financial health evaluation. DEX has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year DEX was profitable.
DEX had a positive operating cash flow in the past year.
In the past 5 years DEX has always been profitable.
DEX had a positive operating cash flow in 4 of the past 5 years.
DEX.DE Yearly Net Income VS EBIT VS OCF VS FCFDEX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.70%, DEX is in line with its industry, outperforming 56.00% of the companies in the same industry.
With a decent Return On Equity value of 7.76%, DEX is doing good in the industry, outperforming 66.00% of the companies in the same industry.
DEX has a Return On Invested Capital of 9.69%. This is in the better half of the industry: DEX outperforms 80.00% of its industry peers.
DEX had an Average Return On Invested Capital over the past 3 years of 9.76%. This is in line with the industry average of 10.42%.
Industry RankSector Rank
ROA 1.7%
ROE 7.76%
ROIC 9.69%
ROA(3y)2.45%
ROA(5y)2.76%
ROE(3y)10.57%
ROE(5y)19.74%
ROIC(3y)9.76%
ROIC(5y)11.86%
DEX.DE Yearly ROA, ROE, ROICDEX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

DEX has a Profit Margin of 0.80%. This is comparable to the rest of the industry: DEX outperforms 56.00% of its industry peers.
In the last couple of years the Profit Margin of DEX has declined.
With a Operating Margin value of 3.22%, DEX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of DEX has grown nicely.
DEX has a worse Gross Margin (29.25%) than 62.00% of its industry peers.
In the last couple of years the Gross Margin of DEX has grown nicely.
Industry RankSector Rank
OM 3.22%
PM (TTM) 0.8%
GM 29.25%
OM growth 3Y8.35%
OM growth 5YN/A
PM growth 3Y-10.2%
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5Y2.36%
DEX.DE Yearly Profit, Operating, Gross MarginsDEX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

DEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, DEX has less shares outstanding
Compared to 5 years ago, DEX has more shares outstanding
DEX has a worse debt/assets ratio than last year.
DEX.DE Yearly Shares OutstandingDEX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
DEX.DE Yearly Total Debt VS Total AssetsDEX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.52 indicates that DEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.52, DEX is doing good in the industry, outperforming 74.00% of the companies in the same industry.
DEX has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
DEX has a worse Debt to Equity ratio (1.14) than 74.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Altman-Z 2.52
ROIC/WACC2.03
WACC4.77%
DEX.DE Yearly LT Debt VS Equity VS FCFDEX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

DEX has a Current Ratio of 0.90. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
DEX has a Current ratio of 0.90. This is amonst the worse of the industry: DEX underperforms 80.00% of its industry peers.
DEX has a Quick Ratio of 0.90. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DEX (0.37) is worse than 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.37
DEX.DE Yearly Current Assets VS Current LiabilitesDEX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

The earnings per share for DEX have decreased strongly by -49.58% in the last year.
Measured over the past years, DEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.71% on average per year.
Looking at the last year, DEX shows a small growth in Revenue. The Revenue has grown by 0.84% in the last year.
DEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.23% yearly.
EPS 1Y (TTM)-49.58%
EPS 3Y-17.71%
EPS 5YN/A
EPS Q2Q%-38.43%
Revenue 1Y (TTM)0.84%
Revenue growth 3Y-6.18%
Revenue growth 5Y-5.23%
Sales Q2Q%-1.07%

3.2 Future

The Earnings Per Share is expected to grow by 19.91% on average over the next years. This is quite good.
DEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.57% yearly.
EPS Next Y13.79%
EPS Next 2Y23.18%
EPS Next 3Y19.91%
EPS Next 5YN/A
Revenue Next Year4.08%
Revenue Next 2Y3.63%
Revenue Next 3Y3.39%
Revenue Next 5Y3.57%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DEX.DE Yearly Revenue VS EstimatesDEX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
DEX.DE Yearly EPS VS EstimatesDEX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.33, the valuation of DEX can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of DEX indicates a rather cheap valuation: DEX is cheaper than 92.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.22. DEX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 6.75 indicates a rather cheap valuation of DEX.
Based on the Price/Forward Earnings ratio, DEX is valued cheaply inside the industry as 86.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DEX to the average of the S&P500 Index (20.86), we can say DEX is valued rather cheaply.
Industry RankSector Rank
PE 8.33
Fwd PE 6.75
DEX.DE Price Earnings VS Forward Price EarningsDEX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

DEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DEX is cheaper than 82.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.07
DEX.DE Per share dataDEX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

DEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DEX's earnings are expected to grow with 19.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y23.18%
EPS Next 3Y19.91%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.33%, DEX is a good candidate for dividend investing.
DEX's Dividend Yield is rather good when compared to the industry average which is at 5.11. DEX pays more dividend than 90.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, DEX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.33%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y23.18%
EPS Next 3Y19.91%
DEX.DE Yearly Income VS Free CF VS DividendDEX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

DELTICOM AG

FRA:DEX (5/2/2025, 7:00:00 PM)

2.25

-0.01 (-0.44%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)05-14 2025-05-14
Inst Owners22.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.37M
Analysts80
Price Target3.88 (72.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.33%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.8%
PT rev (3m)-8.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-20.48%
EPS NY rev (3m)-26.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.11%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE 8.33
Fwd PE 6.75
P/S 0.07
P/FCF N/A
P/OCF 6.86
P/B 0.64
P/tB 2.21
EV/EBITDA 4.07
EPS(TTM)0.27
EY12%
EPS(NY)0.33
Fwd EY14.81%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.33
OCFY14.57%
SpS34.19
BVpS3.51
TBVpS1.02
PEG (NY)0.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.7%
ROE 7.76%
ROCE 14.68%
ROIC 9.69%
ROICexc 10.18%
ROICexgc 15.65%
OM 3.22%
PM (TTM) 0.8%
GM 29.25%
FCFM N/A
ROA(3y)2.45%
ROA(5y)2.76%
ROE(3y)10.57%
ROE(5y)19.74%
ROIC(3y)9.76%
ROIC(5y)11.86%
ROICexc(3y)10.32%
ROICexc(5y)12.68%
ROICexgc(3y)16.92%
ROICexgc(5y)26.93%
ROCE(3y)15.21%
ROCE(5y)18.21%
ROICexcg growth 3Y-17.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.03%
ROICexc growth 5YN/A
OM growth 3Y8.35%
OM growth 5YN/A
PM growth 3Y-10.2%
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5Y2.36%
F-Score6
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Debt/EBITDA 2.24
Cap/Depr 58.28%
Cap/Sales 1.16%
Interest Coverage 5.88
Cash Conversion 18.43%
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.37
Altman-Z 2.52
F-Score6
WACC4.77%
ROIC/WACC2.03
Cap/Depr(3y)47.93%
Cap/Depr(5y)34.33%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.58%
EPS 3Y-17.71%
EPS 5YN/A
EPS Q2Q%-38.43%
EPS Next Y13.79%
EPS Next 2Y23.18%
EPS Next 3Y19.91%
EPS Next 5YN/A
Revenue 1Y (TTM)0.84%
Revenue growth 3Y-6.18%
Revenue growth 5Y-5.23%
Sales Q2Q%-1.07%
Revenue Next Year4.08%
Revenue Next 2Y3.63%
Revenue Next 3Y3.39%
Revenue Next 5Y3.57%
EBIT growth 1Y0.39%
EBIT growth 3Y1.65%
EBIT growth 5YN/A
EBIT Next Year125.93%
EBIT Next 3Y38.19%
EBIT Next 5YN/A
FCF growth 1Y-103.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.29%
OCF growth 3Y-39.47%
OCF growth 5YN/A